ArticleCancer discovery2022

Serial Profiling of Circulating Tumor DNA Identifies Dynamic Evolution of Clinically Actionable Genomic Alterations in High-Risk Neuroblastoma.

Kristopher R Bosse et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.